SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/14/1/20.09.24 Share Price

Warrant

DE000SQ7W3W7

Market Closed - Deutsche Boerse AG 20:47:03 05/07/2024 BST
2.75 EUR -4.51% Intraday chart for SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/14/1/20.09.24
Current month+4.56%
1 month-13.52%
Date Price Change
05/07/24 2.75 -4.51%
04/07/24 2.88 -1.37%
03/07/24 2.92 +0.34%
02/07/24 2.91 +6.99%
01/07/24 2.72 +3.42%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 08:47 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
IssuerLogo Issuer Société Générale Société Générale
WKN SQ7W3W
ISINDE000SQ7W3W7
Date issued 13/01/2023
Strike 14 $
Maturity 20/09/2024 (75 Days)
Parity 1 : 1
Emission price 1.86
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 3.76
Lowest since issue 0.31
Delta0.81x
Omega 4.425
Premium3.61x
Gearing5.48x
Moneyness 1.171
Difference Strike -2.4 $
Difference Strike %-17.14%
Spread 0.02
Spread %0.72%
Intrinsic value 2.214

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.4 USD
Average target price
18.74 USD
Spread / Average Target
+14.24%
Consensus